정맥 내 혈전 용해술을 받은 80세 이상과 미만 뇌경색 환자의 예후와 합병증 비교
Differences of Prognosis and Complications between over and under 80 Years Old Ischemic Stroke Patients Who Received Intravenous Recombinant Tissue Plasminogen Activator

조선대학교 의학연구원
The Medical Journal of Chosun University
제39권 제4호
2014.12

219 - 223 (5 pages)

커버이미지 없음

Proportion of elderly patients is gradually increasing in the republic of Korea. However, intravenous recombinant tissue plasminogen activator (rt-PA) therapy is recently not recommended in elderly acute ischemic stroke patients, although old age is not a proven contraindication to intravenous rt-PA. The purpose of this study was to investigate the safety and prognosis of intravenous thrombolysis in elderly patients.

서론

대상 및 방법

결과

고찰

정맥 내 혈전 용해술을 받은 80세 이상과 미만 뇌경색 환자의 예후와 합병증 비교
Differences of Prognosis and Complications between over and under 80 Years Old Ischemic Stroke Patients Who Received Intravenous Recombinant Tissue Plasminogen Activator

(0)

(0)

(0)

(0)

정맥 내 혈전 용해술을 받은 80세 이상과 미만 뇌경색 환자의 예후와 합병증 비교 Differences of Prognosis and Complications between over and under 80 Years Old Ischemic Stroke Patients Who Received Intravenous Recombinant Tissue Plasminogen Activator

(0)

(0) 팝업 열기 팝업 닫기

(0)

(0)

정맥 내 혈전 용해술을 받은 80세 이상과 미만 뇌경색 환자의 예후와 합병증 비교
Differences of Prognosis and Complications between over and under 80 Years Old Ischemic Stroke Patients Who Received Intravenous Recombinant Tissue Plasminogen Activator

(0)